🇺🇸 FDA
Patent

US 7205411

Aminopyridine derivatives as mGluR5 antagonists

granted A61PA61P25/00A61P25/04

Quick answer

US patent 7205411 (Aminopyridine derivatives as mGluR5 antagonists) held by Addex Pharmaceuticals S.A. expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharmaceuticals S.A.
Grant date
Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P25/00, A61P25/04, A61P25/06, A61P25/14